Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Hematological Disorders”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Looking for participantsNCT06225856
What this trial is testing

An Open-Label, Multicenter, Phase I Study to Evaluate the Safety, Pharmacokinetics and Preliminary Efficacy of YY201 in Patients With Advanced Solid Tumors and Hematological Malignancies

Who this might be right for
Advanced Solid TumorHematological Malignancy
Shanghai Yuyao Biotech Co., Ltd. 96
Early research (Phase 1)UnknownNCT04854681
What this trial is testing

Phase 1 Trial of the TQB2928 Injection in Patients With Advanced Cancers

Who this might be right for
Advanced Solid Tumors and Hematological Malignancies
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 20
Testing effectiveness (Phase 2)Study completedNCT00248430
What this trial is testing

Donor White Blood Cell Infusions and Interleukin-2 in Treating Patients Who Are Undergoing an Autologous Stem Cell Transplant for Relapsed Advanced Lymphoid Cancer

Who this might be right for
Graft Versus Host DiseaseLeukemiaLymphoma+1 more
Fred Hutchinson Cancer Center 20
Very early researchStudy completedNCT00572065
What this trial is testing

Pilot Trial of Arsenic + Cytarabine in Patients With Myelofibrosis

Who this might be right for
Myelofibrosis
Weill Medical College of Cornell University 21
Early research (Phase 1)UnknownNCT00090727
What this trial is testing

Chemotherapy for Patients With Advanced Solid Tumors or Non-Hodgkin's Lymphoma

Who this might be right for
Solid MalignanciesNon-Hodgkin's Lymphoma
Novacea 45
Early research (Phase 1)Study completedNCT00303797
What this trial is testing

Sorafenib and Bortezomib in Treating Patients With Advanced Cancer

Who this might be right for
Refractory Chronic Lymphocytic LeukemiaRefractory Multiple MyelomaStage III Multiple Myeloma+2 more
National Cancer Institute (NCI) 50
Early research (Phase 1)Study completedNCT00004047
What this trial is testing

Chemotherapy in Treating Patients Who Have Hematologic Cancer

Who this might be right for
LeukemiaMyelodysplastic Syndromes
Daiichi Sankyo
Testing effectiveness (Phase 2)Study completedNCT00365287
What this trial is testing

Combination Chemotherapy and Total-Body Irradiation Before Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematologic Cancer, Metastatic Breast Cancer, or Kidney Cancer

Who this might be right for
Breast CancerKidney CancerLeukemia+3 more
Masonic Cancer Center, University of Minnesota 148
Early research (Phase 1)Study completedNCT01725555
What this trial is testing

Assess the Effect of Food on the Bioavailability of the IGF-1R Inhibitor AXL1717 in Patients With Advanced Malignant Tumors

Who this might be right for
Solid TumorsHematological Malignancies
Axelar AB 13
Early research (Phase 1)Study completedNCT03127735
What this trial is testing

BAY1436032 in Patients With Mutant IDH1(mIDH1) Advanced Acute Myeloid Leukemia (AML)

Who this might be right for
Leukemia, Myeloid, Acute
Bayer 27
Testing effectiveness (Phase 2)Looking for participantsNCT07033598
What this trial is testing

Pacritinib vs. Hydroxyurea in Advanced Proliferative Chronic Myelomonocytic Leukemia

Who this might be right for
Leukemia, Myelomonocytic, Chronic
Theradex 66
Early research (Phase 1)Study completedNCT02345382
What this trial is testing

Phase I Dose Escalation of BAY1143572 in Subjects With Acute Leukemia

Who this might be right for
Leukemia
Bayer 42
Not applicableStudy completedNCT03375567
What this trial is testing

Global Response Assessment by Advanced Imaging and Myeloma Lesion Biopsies During Induction Therapy of Multiple Myeloma With Carfilzomib Lenalidomide Dexamethasone

Who this might be right for
Multiple Myeloma
Yale University 28
Early research (Phase 1)Ended earlyNCT00003567
What this trial is testing

Gene Therapy and Chemotherapy in Treating Patients With Advanced Solid Tumors or Non-Hodgkin's Lymphoma

Who this might be right for
Brain and Central Nervous System TumorsLymphomaUnspecified Adult Solid Tumor, Protocol Specific
Case Comprehensive Cancer Center 8
Early research (Phase 1)Study completedNCT00891592
What this trial is testing

Umbilical Cord Blood Transplant for Hematological Malignancies

Who this might be right for
CMLAMLMDS+4 more
University of Pennsylvania 5
Not applicableStudy completedNCT02108028
What this trial is testing

Study of Voicing My CHOiCES as a Tool for Advanced Care Planning in Young Adults With Cancer

Who this might be right for
HIVCancerChronic Granulomatous Disease+1 more
National Cancer Institute (NCI) 272
Early research (Phase 1)Study completedNCT00004245
What this trial is testing

Sodium Salicylate in Treating Patients With Advanced Myelodysplastic Syndrome, Acute Myelogenous Leukemia, or Chronic Lymphocytic Leukemia

Who this might be right for
LeukemiaMyelodysplastic SyndromesMyelodysplastic/Myeloproliferative Neoplasms
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Active Not RecruitingNCT06308822
What this trial is testing

Testing JNJ-42756493 (Erdafitinib) as Potentially Targeting Treatment in Cancers With FGFR Amplifications (MATCH-Subprotocol K1)

Who this might be right for
Advanced LymphomaAdvanced Malignant Solid NeoplasmRefractory Lymphoma+2 more
National Cancer Institute (NCI) 35
Testing effectiveness (Phase 2)Active Not RecruitingNCT04439253
What this trial is testing

Testing Crizotinib as a Potential Targeted Treatment in Cancers With ROS1 Genetic Changes (MATCH-Subprotocol G)

Who this might be right for
Advanced LymphomaAdvanced Malignant Solid NeoplasmHematopoietic and Lymphoid Cell Neoplasm+3 more
National Cancer Institute (NCI) 4
Testing effectiveness (Phase 2)Study completedNCT00004105
What this trial is testing

Combination Chemotherapy in Treating Patients With Advanced Cancer

Who this might be right for
LeukemiaLymphomaSarcoma+1 more
NYU Langone Health
Next Page